Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma
Authors:
- 23 February 2012
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 250 (10) , 1533-1540
Abstract
Background The aim of this work is to report on conservation of visual acuity after eccentric ruthenium106 (Ru-106) brachytherapy of posterior choroidal melanoma. Methods Fifty-four patients with choroidal melanoma extending to within 5 mm of the optic disc or fovea were treated at a single institution during the 3 years up to July 31, 2007. The plaque was positioned eccentrically with its posterior edge aligned with the posterior tumor margin to reduce the radiation dose to the optic disc and fovea. The main outcome measures were local tumor control and conservation of vision of 6/12 or better, according to baseline variables. Results The tumors had a mean longest basal diameter of 12.0 mm and a mean thickness of 3.1 mm. The posterior tumor margin extended to within 3 mm of the fovea in 30 patients (56%). In the 24 eyes with the posterior tumor margin located 3.1–5.0 mm from the fovea, 74.9% retained visual acuity of 6/12 or better 4 years after treatment (95% confidence interval [CI], 55.5–94.3%). In the 30 eyes with tumor extension to within 3.0 mm of the fovea, then 3 years after treatment only 25.3% retained such vision (95% CI, 5.3–45.3%). Recurrence at the posterior tumor margin occurred in two patients. Conclusions Eccentric ruthenium106 plaque radiotherapy of posterior choroidal melanoma achieves good rates of local tumor control and conservation of vision if special measures are taken to ensure that the plaque is positioned correctly.Keywords
This publication has 36 references indexed in Scilit:
- Predicting local control of choroidal melanomas following 106Ru plaque brachytherapyBritish Journal of Ophthalmology, 2010
- Ruthenium Brachytherapy for Uveal Melanoma, 1979–2003Survival and Functional Outcomes in the Swedish PopulationOphthalmology, 2005
- Intraoperative echographic localization of iodine-125 episcleral plaque for brachytherapy of choroidal melanomaAmerican Journal of Ophthalmology, 2000
- Risk factors for radiation maculopathy and papillopathy after intraocular irradiation☆Ophthalmology, 1999
- Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvementAmerican Journal of Ophthalmology, 1999
- Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.British Journal of Ophthalmology, 1996
- Iodine‐125 Irradiation of Choroidal Melanoma: Clinical Experience from the Prince of Wales and Sydney Eye HospitalsAustralasian Radiology, 1992
- The use of iodine-125 plaques in the treatment of retinoblastomaOphthalmic Paediatrics and Genetics, 1987
- Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience.British Journal of Ophthalmology, 1986
- Progress in the use of iodine therapy for tumours of the eyeBritish Journal of Radiology, 1980